Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. For more than 30 years, we have done just that. As the global leader in manufacturing and supplying sodium hyaluronate (NaHy), more than 90 million patients have benefited from our certified pharmaceutical grade NaHy. We are using our expertise in handling highly viscous solutions to expand our contract development and commercial manufacturing services to solve complex drug development challenges. Lifecore Biomedical, Inc. is a wholly owned subsidiary of Landec Corporation (Nasdaq: LNDC). We remain fully committed to the quality and service that ensures our products meet the highest standards set by the United States Food and Drug Administration, the European Community and other international agencies.